Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of ExoDx™ Prostate (IntelliScore) in Men With Prior Negative Prostate Biopsy Presenting for a Repeat Biopsy

NCT04357717 is registered in ClinicalTrials.gov with Exosome Diagnostics, Inc. as lead sponsor.

NCT NCT04357717
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04357717 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of ExoDx™ Prostate (IntelliScore) in Men With Prior Negative Prostate Biopsy Presenting for a Repeat Biopsy
Lead sponsor
Exosome Diagnostics, Inc.
Phase
Observational
Overall status
Terminated
Start date
March 15, 2020
Completion date
September 1, 2021
Enrollment
150 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer